Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Omacor Wins - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Omacor Wins

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Omacor Wins
Approval In Norway
Omacor, produced by Pronova Biocare, Lysaker, Norway, has been approved in Norway for the treatment of post-infarct patients. The formulation is more than 90% omega 3 (84% EPA and DHA) and one capsule per day dosing enhances patient compliance. In clinical trials, side effects were few, transient and mild.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters